Form 8-K - Current report:
SEC Accession No. 0001193125-25-134980
Filing Date
2025-06-04
Accepted
2025-06-04 16:54:22
Documents
15
Period of Report
2025-06-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d932694d8k.htm   iXBRL 8-K 38293
2 EX-10.1 d932694dex101.htm EX-10.1 115435
3 EX-99.1 d932694dex991.htm EX-99.1 8554
  Complete submission text file 0001193125-25-134980.txt   363970

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA prgo-20250602.xsd EX-101.SCH 5222
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prgo-20250602_def.xml EX-101.DEF 15215
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE prgo-20250602_lab.xml EX-101.LAB 25947
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prgo-20250602_pre.xml EX-101.PRE 16443
18 EXTRACTED XBRL INSTANCE DOCUMENT d932694d8k_htm.xml XML 10794
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 251023862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)